ACTSI Investigator Dr. Andreas Kalogeropoulos in the News

Andreas Kalogeropoulos, MD, PhD is an ACTSI investigator and an assistant professor in the Division of Cardiology, Emory School of Medicine. His research focuses on applications of echocardiography in advanced heart failure and congenital heart disease; risk factors, biomarkers, and predictive models in advanced heart failure; and risk stratification for heart failure in older adults. He received an Emory University Research Committee & ACTSI Award to investigate the course of right ventricular function in patients with heart failure who receive a left ventricular assist device. Kalogeropoulos received follow-on funding from that project through the AHA Scientist Development Grant. This was a four-year award ($70,000/year) given to junior faculty as their first independent step. Dr. Kalogeropoulos is a hard rock fan and, in his free time, he enjoys playing his electric guitar – preferably loud.

New York Times | Salt may not affect heart risks
January 26, 2015

TIME | Modern Healthcare | Tech Times | Daily MailOlder adults may be OK to eat more salt than previously thought
January 19, 2015

Emory News Center | Salt intake among older Americans not linked to heart disease or death, study shows
January 10, 2015

Emory News Center | Heart study aims to identify at-risk patients after pump implant
September 26, 2013

Medical Xpress | Heart study aims to identify at-risk patients after pump implant
September 24, 2013

Kalogeropoulos received a grant from Critical Diagnostics to investigate the role of ST2, a novel biomarker, in patients with ambulatory (Stage C) heart failure. ST2 is a soluble protein expressed by the heart in response to disease or injury. He will evaluate the prognostic value of baseline and serial ST2 assessments, as measured by Critical Diagnostics’ Presage® ST2 assay, in the Atlanta Cardiomyopathy Consortium, an Emory University-funded cohort study involving 330 patients with Stage C heart failure.


“The Right Ventricular Function After Left Ventricular Assist Device (RVF-LVAD) study: rationale and preliminary results.” Eur Heart J Cardiovasc Imaging. 2015 Jul 9. pii: jev162. [Epub ahead of print]

“Validation of clinical scores for right ventricular failure prediction after implantation of continuous-flow left ventricular assist devices.” Heart Lung Transplant. 2015 Jun 1. pii: S1053-2498(15)01262-0.

“Dietary Sodium Content, Mortality, and Risk for Cardiovascular Events in Older Adults: The Health, Aging, and Body Composition (Health ABC) Study.” JAMA Intern Med. 2015 Jan 19.

“Inotrope use and outcomes among patients hospitalized for heart failure: impact of systolic blood pressure, cardiac index, and etiology.” J Card Fail. 2014 Aug;20(8):593-601.

“Association of electrocardiogram abnormalities and incident heart failure events.” Am Heart J. 2014 Jun;167(6):869-75.e3.

“Incident heart failure in relation to vascular disease: Insights from the Health, Aging, and Body Composition Study.” Eur J Heart Fail 2014 Feb 27. doi: 10.1002/ejhf.69.

“High sensitivity C-reactive protein in acute heart failure: Insights from the ASCEND-HF trial.” J Card Fail 2014 Feb 11. pii: S1071-9164(14)00065-7.

“Cardiorespiratory fitness and risk of heart failure: a population-based follow-up study.” Eur J Heart Fail 2014 Feb;16(2):180-8.